Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Bennett CL, et al. JAMA. 2008 Feb 27;299(8):914-24. doi: 10.1001/jama.299.8.914. JAMA. 2008. PMID: 18314434 Review.
Cancer- and chemotherapy-induced anemia.
Rodgers GM 3rd, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R; National Comprehensive Cancer Network. Rodgers GM 3rd, et al. Among authors: bennett cl. J Natl Compr Canc Netw. 2008 Jul;6(6):536-64. doi: 10.6004/jnccn.2008.0042. J Natl Compr Canc Netw. 2008. PMID: 18597709 No abstract available.
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB 3rd, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL. Richey EA, et al. Among authors: bennett cl. J Clin Oncol. 2009 Sep 10;27(26):4398-405. doi: 10.1200/JCO.2008.21.1961. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636013 Free PMC article.
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Dorr DA, et al. Among authors: bennett cl. Clin Cancer Res. 2009 Jun 1;15(11):3850-5. doi: 10.1158/1078-0432.CCR-08-1811. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458059 Free PMC article.
Upping recruitment in clinical trials: are the costs worth it?
McKoy JM, Samaras AT, Luu TH, Bennett CL. McKoy JM, et al. Among authors: bennett cl. Onkologie. 2009 Jul;32(7):378-9. doi: 10.1159/000223742. Epub 2009 Jun 20. Onkologie. 2009. PMID: 19556813 Free article. No abstract available.
Gadolinium-associated nephrogenic systemic fibrosis.
McKoy JM, Laumann A, Samaras A, Lacouture M, West D, Raisch D, Obadina E, Fajolu O, Reilly L, Bennett CL. McKoy JM, et al. Among authors: bennett cl. Community Oncol. 2008;5(6):325-326. doi: 10.1016/s1548-5315(11)70463-6. Community Oncol. 2008. PMID: 19920874 Free PMC article.
686 results